DK168523B1 - N-substituerede 2-aminothiazoler, fremgangsmåde til deres fremstilling og præparater, der indeholder dem - Google Patents

N-substituerede 2-aminothiazoler, fremgangsmåde til deres fremstilling og præparater, der indeholder dem Download PDF

Info

Publication number
DK168523B1
DK168523B1 DK197786A DK197786A DK168523B1 DK 168523 B1 DK168523 B1 DK 168523B1 DK 197786 A DK197786 A DK 197786A DK 197786 A DK197786 A DK 197786A DK 168523 B1 DK168523 B1 DK 168523B1
Authority
DK
Denmark
Prior art keywords
group
formula
acid
hydrogen atom
alkyl
Prior art date
Application number
DK197786A
Other languages
Danish (da)
English (en)
Other versions
DK197786A (da
DK197786D0 (da
Inventor
Claude Coquelet
Daniel Sincholle
Claude Bonne
Alain Alazet
Original Assignee
Chauvin Lab Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chauvin Lab Sa filed Critical Chauvin Lab Sa
Publication of DK197786D0 publication Critical patent/DK197786D0/da
Publication of DK197786A publication Critical patent/DK197786A/da
Application granted granted Critical
Publication of DK168523B1 publication Critical patent/DK168523B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/42—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK197786A 1985-04-30 1986-04-30 N-substituerede 2-aminothiazoler, fremgangsmåde til deres fremstilling og præparater, der indeholder dem DK168523B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8506568A FR2581063B1 (fr) 1985-04-30 1985-04-30 Amino-2 thiazoles n-substitues, leur procede de preparation et leur application en therapeutique
FR8506568 1985-04-30

Publications (3)

Publication Number Publication Date
DK197786D0 DK197786D0 (da) 1986-04-30
DK197786A DK197786A (da) 1986-10-31
DK168523B1 true DK168523B1 (da) 1994-04-11

Family

ID=9318828

Family Applications (1)

Application Number Title Priority Date Filing Date
DK197786A DK168523B1 (da) 1985-04-30 1986-04-30 N-substituerede 2-aminothiazoler, fremgangsmåde til deres fremstilling og præparater, der indeholder dem

Country Status (11)

Country Link
US (1) US4785008A (ja)
EP (1) EP0202157B1 (ja)
JP (1) JPH0629270B2 (ja)
AT (1) ATE45734T1 (ja)
CA (1) CA1289144C (ja)
DE (1) DE3665176D1 (ja)
DK (1) DK168523B1 (ja)
ES (1) ES8900045A1 (ja)
FR (1) FR2581063B1 (ja)
IE (1) IE59141B1 (ja)
PT (1) PT82480B (ja)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995009619A2 (en) * 1993-10-04 1995-04-13 The Wellcome Foundation Limited Substituted urea and isothiourea derivatives as no synthase inhibitors
EP0254259A3 (en) * 1986-07-21 1989-11-23 Otsuka Pharmaceutical Factory, Inc. P-aminophenol derivatives
JPS6339868A (ja) * 1986-08-04 1988-02-20 Otsuka Pharmaceut Factory Inc ジ低級アルキルフエノ−ル誘導体
FR2612187B1 (fr) * 1987-03-12 1989-07-21 Sanofi Sa Derives du thiazole actifs sur le systeme cholinergique, leur procede de preparation et compositions pharmaceutiques en contenant
AU628485B2 (en) * 1989-02-23 1992-09-17 Otsuka Pharmaceutical Factory, Inc. P-aminophenol derivative and production and application thereof
JPH03111178U (ja) * 1990-02-27 1991-11-14
US6225305B1 (en) 1993-10-04 2001-05-01 Glaxo Wellcome Inc. Substituted urea and isothiorea derivatives as no synthase inhibitors
US6297276B1 (en) 1993-10-04 2001-10-02 Glaxosmithkline Substituted urea and isothiourea derivatives as no synthase inhibitors
US6090846A (en) * 1994-06-01 2000-07-18 Glaxo Wellcome Inc. Substituted urea and isothiourea derivatives as no synthase inhibitors
GB9418912D0 (en) * 1994-09-20 1994-11-09 Fisons Corp Pharmaceutically active compounds
US6100282A (en) 1998-01-02 2000-08-08 Hoffman-La Roche Inc. Thiazole derivatives
JP4693247B2 (ja) * 1999-04-28 2011-06-01 有限会社ケムフィズ 複素環カルボン酸誘導体
KR20020027635A (ko) * 1999-09-10 2002-04-13 폴락 돈나 엘. 티로신 키나제 억제제
WO2007002461A1 (en) * 2005-06-23 2007-01-04 Dr. Reddy's Laboratories Ltd. 3,4-substituted thiazoles as ampk activators
BRPI0613555A2 (pt) * 2005-07-04 2011-01-18 Reddys Lab Ltd Dr derivados de tiazóis como ativador de ampk
KR20100125424A (ko) * 2008-03-19 2010-11-30 바이엘 크롭사이언스 아게 살진균제 히드록시모일-테트라졸 유도체
US10696638B2 (en) 2017-12-26 2020-06-30 Industrial Technology Research Institute Compounds for inhibiting AGC kinase and pharmaceutical compositions comprising the same
EA202092691A1 (ru) 2018-05-29 2021-04-21 Церси Терапьютикс, Инк. Соединения для устранения боли, композиции, содержащие их, и способы их применения
BR112021022478A2 (pt) 2019-05-10 2022-01-25 Cersci Therapeutics Inc Composto de fórmula i, composição farmacêutica, forma cristalina do composto de fórmula i, uso do composto e uso da forma cristalina

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL264710A (ja) * 1960-05-13
US3299087A (en) * 1961-04-24 1967-01-17 Geigy Chem Corp Nu, nu'-bis-(thiazolyl)-phenylenediamines
US3467666A (en) * 1966-11-07 1969-09-16 Geigy Chem Corp 2-substituted aminothiazoles
BE795907A (fr) * 1972-02-25 1973-06-18 Luso Farmaco Inst 2-amino-4-arylthiazoles 5-substitues et leur preparation
JPS5742629B2 (ja) * 1973-10-29 1982-09-09
JPS565747B2 (ja) * 1973-10-24 1981-02-06
JPS5833870B2 (ja) * 1976-01-12 1983-07-22 塩野義製薬株式会社 チアゾリン誘導体
DK150068C (da) * 1978-06-02 1987-06-29 Pfizer Analogifremgangsmaade til fremstilling af aminothiazoler

Also Published As

Publication number Publication date
ES8900045A1 (es) 1988-11-16
PT82480A (en) 1986-05-01
CA1289144C (en) 1991-09-17
EP0202157A1 (fr) 1986-11-20
US4785008A (en) 1988-11-15
FR2581063A1 (fr) 1986-10-31
FR2581063B1 (fr) 1987-07-17
DE3665176D1 (en) 1989-09-28
JPS6277375A (ja) 1987-04-09
DK197786A (da) 1986-10-31
IE59141B1 (en) 1994-01-12
IE861119L (en) 1986-10-30
EP0202157B1 (fr) 1989-08-23
PT82480B (pt) 1988-03-03
ATE45734T1 (de) 1989-09-15
ES554503A0 (es) 1988-11-16
JPH0629270B2 (ja) 1994-04-20
DK197786D0 (da) 1986-04-30

Similar Documents

Publication Publication Date Title
DK168523B1 (da) N-substituerede 2-aminothiazoler, fremgangsmåde til deres fremstilling og præparater, der indeholder dem
US4554276A (en) 2-Amino-5-hydroxy-4-methylpyrimidine derivatives
JPH01143856A (ja) 抗アレルギーおよび抗炎症剤用２−アリール置換複素環式化合物
DK167614B1 (da) Quinolinderivater
HU188852B (en) Process for producing thiazolidine derivatives active against gastric ulcer and intestinal ulcer
US3957850A (en) Phenylacetic acid derivatives
EP0228959B1 (en) Aminostyryl compound, leukotriene antagonistic composition containing the same as effective ingredients and method of antagonizing srs by employing the same
JPH0717589B2 (ja) 新規１，３―ジカルボニル化合物およびその組成物
JPH072770A (ja) 新規な置換インドール類、その製造法及びそのインドール類を含有する製剤組成物
JPS609716B2 (ja) １，２―ベンズインチアゾリン―３―オン類、それらの製造法および医薬としての使用
FI83650C (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 4-(isoxazolyl)-tiazol-2-oxaminsyraderivat.
JP3140494B2 (ja) 置換されたフエニルアセチレン、これを含有する薬剤、この化合物及び薬剤を製造する方法
JPH03190872A (ja) 新規なチオフェン誘導体
US4034113A (en) Treatment of senile geriatric patients to restore performance
DK170047B1 (da) Med basiske heterocycliske grupper substituerede 5-halogen-thienoisothiazol-3(2H)-on-1,1-dioxider og salte deraf, fremgangsmåde til fremstilling af sådanne forbindelser, farmaceutiske præparater indeholdende disse forbindelser og forbindelsernes anvendelse ved fremstilling af lægemidler til behandling af angsttilstande
DK158944B (da) Analogifremgangsmaade til fremstilling af substituerede methylimidazolforbindelser
JPS6399057A (ja) グリシン誘導体
US4600721A (en) Pharmaceutical preparation
US5179089A (en) Isoquinoline compounds, compositions and use
NL8003385A (nl) (3-alkylamino-2-hydroxypropoxy)-furan-2-carbonzuur- aniliden en werkwijzen voor het bereiden en toepassen van deze verbindingen.
CA1211441A (fr) Procede de preparation de nouvelles piperidinoguanidines substituees, et des compositions pharmaceutiques en renfermant
JPH0124146B2 (ja)
JP2967231B2 (ja) １，４―チアジン誘導体
FR2528844A1 (fr) Nouvelles thiazolyl-2 hydrazones, leur procede de preparation et leur application en therapeutique
JPH0625213A (ja) フラボン誘導体

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed